| 
Mechanism5-HT receptor antagonists   | 
Active Org.-  | 
 | 
Active Indication-  | 
 | 
Drug Highest PhaseDiscontinued  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
 | 
Mechanism5-HT receptor antagonists [+1]    | 
Active Org.-  | 
 | 
Active Indication-  | 
 | 
Drug Highest PhaseDiscontinued  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
100 Clinical Results associated with Spofa As
0  Patents (Medical) associated with Spofa As
100 Deals associated with Spofa As
100 Translational Medicine associated with Spofa As